Jade Biosciences, Inc.
JBIO
$8.03
$0.131.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.23M | 3.36M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.78M | 23.38M | |||
| Operating Income | -27.78M | -23.38M | |||
| Income Before Tax | -32.13M | -38.17M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.13M | -38.17M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.13M | -38.17M | |||
| EBIT | -27.78M | -23.38M | |||
| EBITDA | -27.78M | -- | |||
| EPS Basic | -0.86 | -8.86 | |||
| Normalized Basic EPS | -0.57 | -4.14 | |||
| EPS Diluted | -0.86 | -8.86 | |||
| Normalized Diluted EPS | -0.57 | -4.14 | |||
| Average Basic Shares Outstanding | 28.43M | 3.43M | |||
| Average Diluted Shares Outstanding | 28.43M | 3.43M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||